Cargando…
Astragalus Polysaccharide Suppresses Skeletal Muscle Myostatin Expression in Diabetes: Involvement of ROS-ERK and NF-κB Pathways
Objective. The antidiabetes drug astragalus polysaccharide (APS) is capable of increasing insulin sensitivity in skeletal muscle and improving whole-body glucose homeostasis. Recent studies suggest that skeletal muscle secreted growth factor myostatin plays an important role in regulating insulin si...
Autores principales: | Liu, Min, Qin, Jian, Hao, Yarong, Luo, Jun, Luo, Tao, Wei, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880770/ https://www.ncbi.nlm.nih.gov/pubmed/24454989 http://dx.doi.org/10.1155/2013/782497 |
Ejemplares similares
-
Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF‐κB
por: Sriram, Sandhya, et al.
Publicado: (2011) -
Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway
por: Guo, Mingfei, et al.
Publicado: (2023) -
Angiotensin (1-7) Decreases Myostatin-Induced NF-κB Signaling and Skeletal Muscle Atrophy
por: Aravena, Javier, et al.
Publicado: (2020) -
Astragalus polysaccharides attenuate pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition and NF-κB pathway activation
por: Zhang, Rui, et al.
Publicado: (2020) -
Myostatin in the Pathophysiology of Skeletal Muscle
por: Carnac, Gilles, et al.
Publicado: (2007)